You are about to leave jnjmedicaldevices.com. By clicking to continue, you will be taken to a web site governed by their own Legal and Privacy Policies.
Communication Resources for Healthcare Professionals
Proud to partner with Colorectal Cancer Alliance
During the COVID-19 pandemic, colorectal cancer screenings dropped roughly 90% and diagnosis fell by 32%.¹ Now more than ever, patients need to hear that it’s safe to get screened.
- Periyanayagam, U., MD, MPH, Dwyer, A., Kim, J., Garcia, R., MPH, Worrall, S., MPH, & Davis, A., MPPA. (2020). New Colorectal Cancer Diagnoses Fall by One-Third as Colonoscopy Screenings and Biopsies Grind to a Halt During Height of COVID-19 (pp. 1-6, Research Brief). KomodoHealth™.
Johnson & Johnson Medical Devices Companies Elective Surgery Survey. Accessed August 4, 2020. About the Survey: This survey was conducted online within the United States by The Harris Poll on behalf of DePuy Synthes from July 9-13, 2020 among 2,016 U.S. adults ages 18 and older. This online survey is not based on a probability sample and therefore no estimate of theoretical sampling error can be calculated. (CLICK TO PDF)
The information on this site is for educational purposes only and is not medical advice. Always talk to your doctor before you make decisions about your health.
For additional information, please contact us at [email protected]